| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 160.7K | $9.32M | - | |
| CEO | 133.2K | $7.72M | -18,198 | |
| CFO | 106.5K | $6.17M | - | |
| Other | 76.8K | $4.45M | -17,000 | |
| VP | 29.0K | $1.68M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $74.99 | $599,909.18 | -3.9% | +4.1% | -51.8% | |
| May 1, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $61.74 | $102,921.27 | -1.8% | +25.4% | -44.7% | |
| May 1, 2024 | Wassil Jim53 | Chief Operating Officer | Sell | 3,000 | $61.65 | $184,942.01 | -0.5% | +25.4% | -44.7% | |
| May 1, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 2,616 | $61.70 | $161,419.23 | -0.3% | +25.4% | -44.7% | |
| Apr 23, 2024 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 15,000 | $61.92 | $928,845.00 | -3.0% | +38.1% | -45.5% | |
| Apr 18, 2024 | Guggenhime Andrew46 | President And CFO | Sale+OE | 8,000 | $61.27 | $490,199.41 | -4.0% | +34.2% | -49.4% | |
| Apr 1, 2024 | Eydelman Mikhail67 | SVP, Gen Counsel &Corp Sec | Sale+OE | 1,667 | $66.73 | $111,234.14 | -2.6% | +15.3% | -51.7% | |
| Apr 1, 2024 | Wassil Jim53 | Chief Operating Officer | Sell | 3,000 | $66.69 | $200,065.55 | -0.7% | +15.3% | -51.7% | |
| Apr 1, 2024 | Pickering Grant50 | Chief Executive Officer | Sell | 2,616 | $66.71 | $174,501.51 | -0.4% | +15.3% | -51.7% | |
| Mar 25, 2024 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 15,000 | $66.93 | $1,003,978.40 | -1.5% | +14.2% | +8.3% |